Data / Form D filings / Vitalis Therapeutics, Inc.
Vitalis Therapeutics, Inc.: Form D filing
Vitalis Therapeutics, Inc., a pharmaceuticals company in New York, NY, filed a Form D with the SEC in 2025. The latest, on February 19, 2025, reports $2 million sold of a $3 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 93 4TH AVENUE, #19, New York, NY, 10003
- Phone
- (646) 831-7338
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2026886
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2025 | New notice | $3,004,968 | $1,954,956 | $1,050,012 | 14 | Dec 13, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph Habboushe | Director, Executive Officer |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Feb 17, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vitalis Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.